News

The jury also found that Gore willfully infringed the patent. In a second phase of the trial, the court is currently assessing Gore’s assertion that the patent is

The loan is convertible, at Abiomed’s option, into common shares of WorldHeart at a conversion price of approximately $1.75 per share, resulting in an approximately 19.9% ownership interest

The submission is based on two fixed-dose, randomized, double-blind, placebo-controlled efficacy and safety studies that evaluated rotigotine for the treatment of moderate-to-severe idiopathic restless legs syndrome (RLS) in

NsG0202 consists of an implantable encapsulated cell (EC) biodelivery device that secretes nerve growth factor (NGF). NGF has shown to have neuroprotective and regenerative effects when delivered to

According to the evidence presented at trial, Acumed’s invention, the Polarus Humeral Rod, helped build the company. But Stryker, a medical implant company had tried to copy the

Boston Scientific had been a strategic business partner with Celsion, as the US marketer of Prolieve Thermodilatation which is used for the treatment of benign prostatic hyperplasia. In

The drug candidate will be evaluated in one or more solid tumor indications. Upon Phase II initiation, Curis will be eligible to receive additional cash milestone payments from

Davanat is a new chemical entity of the galactomannan carbohydrate polymer family composed of mannose and galactose. Davanat, in combination with chemotherapies, is currently in Phase II trials

The data showed that a single treatment with NX-1207 produced durable significant improvement. Statistical analysis of the controlled data showed that the results for NX-1207 reached statistical significance